Masson Kristina 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Masson Kristina（CIK 1950501）在 1 家公司共报告 21 笔 SEC Form 4 内部人交易（最近一笔 2026-08-27）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-27 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 14,036 | $30,969 |
| 2026-08-20 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 1,229 | $2,470 |
| 2026-08-20 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 484 | $973 |
| 2026-05-26 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 13,729 | $24,575 |
| 2026-05-20 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 买入 | 180,095 | $0 |
| 2026-05-20 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 买入 | 72,706 | $0 |
| 2026-05-18 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 1,253 | $2,406 |
| 2026-05-18 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 490 | $941 |
| 2026-02-24 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 14,265 | $21,825 |
| 2026-02-18 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 1,302 | $2,122 |
| 2026-02-18 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 579 | $944 |
| 2026-01-16 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 买入 | 49,000 | $82,320 |
| 2025-11-25 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 19,904 | $45,779 |
| 2025-11-18 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 59,765 | $133,874 |
| 2025-11-18 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 490 | $1,098 |
| 2025-08-25 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 19,905 | $26,275 |
| 2025-08-18 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 59,766 | $83,075 |
| 2025-08-18 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 490 | $681 |
| 2025-05-23 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 19,904 | $22,890 |
| 2025-05-16 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 59,766 | $68,133 |
| 2025-05-16 | Acrivon Therapeutics, Inc. (ACRV) | EVP - Business Operations | 卖出 | 491 | $560 |
来源：SEC Form 4 申报文件 · 截至 2026-08-27